NOW Ep115: The great rewiring of global healthcare

Loading player...
Medicine is moving into a world where software spots patterns before humans sense symptoms, and breakthrough therapies can move markets faster than earnings reports. Longevity is rising, costs are climbing, and global healthcare systems are left to wonder whether innovation will save them or bankrupt them first.

In this episode of No Ordinary Wednesday, Jeremy Maggs speaks with Dr Jimmy Muchechetere from Investec Investment Management UK to unravel the forces rewiring global healthcare, from the boom-and-bust frenzy around weight-loss drugs to AI promising to predict illness long before it strikes.

Podcast key moments:

00:00 Introduction
01:34 Are we reaching the limits of human longevity?
02:13 Are weight-loss drugs a bubble or a structural shift?
04:13 How the White House–pharma deal changes drug pricing
06:58 Who wins and loses in a world with fewer illnesses?
08:10 Why longevity is becoming a macroeconomic risk
10:28 Who holds power in an AI-driven pharmaceutical world?
12:27 How to maintain trust when AI outperforms humans in diagnostics
13:51 How AI is transforming preventative medicine
16:27 Will data expertise surpass clinical expertise?
17:35 Who is accountable when AI influences medical decisions?
18:57 Why regulation must catch up with rapid AI innovation
20:47 Will AI-driven healthcare widen inequality?
22:39 How demographics and geopolitics shape healthcare tailwinds
23:56 How leaders build conviction in a VUCA healthcare landscape
25:22 The next frontier in personalised and preventative medicine

Read more on www.investec.com/now

Hosted by seasoned broadcaster, Jeremy Maggs, the No Ordinary Wednesday podcast unpacks the latest economic, business, and political news in South Africa, with an all-star cast of investment and wealth managers, economists and financial planners from Investec. Listen in every second Wednesday for an in-depth look at what's moving markets, shaping the economy, and changing the game for your wallet and your business.
Chapters
  • 00:00 Introduction
  • 01:34 Are we reaching the limits of human longevity?
  • 02:13 Are weight-loss drugs a bubble or a structural shift?
  • 04:13 How the White House–pharma deal changes drug pricing
  • 06:58 Who wins and loses in a world with fewer illnesses?
  • 08:10 Why longevity is becoming a macroeconomic risk
  • 10:28 Who holds power in an AI-driven pharmaceutical world?
  • 12:27 How to maintain trust when AI outperforms humans in diagnostics
  • 13:51 How AI is transforming preventative medicine
  • 16:27 Will data expertise surpass clinical expertise?
  • 17:35 Who is accountable when AI influences medical decisions?
  • 18:57 Why regulation must catch up with rapid AI innovation
  • 20:47 Will AI-driven healthcare widen inequality?
  • 22:39 How demographics and geopolitics shape healthcare tailwinds
  • 23:56 How leaders build conviction in a VUCA healthcare landscape
  • 25:22 The next frontier in personalised and preventative medicine
18 Nov 2025 English South Africa Business · Investing

Other recent episodes

Investec Minds Ep 5 | Nick Holland on decisions that reshaped Gold Fields

Some of Nick Holland’s biggest decisions took years to prove their worth. The former Gold Fields CEO joins Investec’s Nkateko Mathonsi to discuss the unbundling that created Sibanye Gold, and his backing of the Chilean mine Salares Norte long before production began. He explains why safety meant stopping production, and…
10 Nov 43 min

Macro Monday Ep139: The three major effects of the US midterms

Democratic Party control of the US House of Representatives and Senate has had three broad market implications: data centre buildouts are unpopular with voters; Congress will likely limit military escalation in the Middle East (which could bring down energy prices); and slower artificial intelligence-linked investment could be good for US…
9 Nov 6 min

No Ordinary Wednesday | Has the AI boom got ahead of itself?

AI agents have entered the workplace, robots are edging closer to our homes and billions continue to flow into the infrastructure powering artificial intelligence. But as technology advances, are the returns keeping pace with expectations? In this episode of No Ordinary Wednesday, Investec Global Equity analysts David Smith and Zane…
3 Nov 31 min

Macro Monday Ep138: The beats go on for US equities

Global equities continue to advance, while US corporate earnings continue to beat expectations. Taking into account these ongoing beats, notes Global Chief Investment Officer Chris Holdsworth, the overall US market now trades at just under 20 times earnings, which is not excessive by historical standards.
2 Nov 8 min

Macro Monday Ep137: Mortgage market an orange light for the US economy

The US economy continues to grow, thanks to ongoing investment into AI, and despite federal government indebtedness and higher inflation because of rising fuel prices. One area where the strain is showing though, says Global Chief Investment Officer Chris Holdsworth, is in the housing market, where mortgage rates are climbing…
26 Oct 8 min